Annotation (Toggle Detail/Summary View) Gene-Chemical Interaction AnnotationsTerm | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane | increases expression | EXP | | 6480464 | 2,2-bis(4-hydroxyphenyl)-1,1,1-trichloroethane results in increased expression of CCNB2 mRNA | CTD | PMID:20826375 | 17alpha-ethynylestradiol | affects expression | EXP | | 6480464 | Ethinyl Estradiol affects the expression of CCNB2 mRNA | CTD | PMID:17555576 | 17alpha-ethynylestradiol | affects expression | ISO | RGD:1308176 | 6480464 | Ethinyl Estradiol affects the expression of CCNB2 mRNA | CTD | PMID:17351261 | 17alpha-ethynylestradiol | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCNB2 mRNA | CTD | PMID:17942748 | 17alpha-ethynylestradiol | increases expression | EXP | | 6480464 | Ethinyl Estradiol results in increased expression of CCNB2 mRNA | CTD | PMID:17942748 | 17beta-estradiol | increases expression | ISO | RGD:1317801 | 6480464 | Estradiol results in increased expression of CCNB2 mRNA | CTD | PMID:16474171 PMID:15897899 | 17beta-estradiol | increases expression | ISO | RGD:1317801 | 6480464 | Estradiol results in increased expression of CCNB2 mRNA | CTD | PMID:15897899 more ... | 17beta-estradiol | increases expression | ISO | RGD:1317801 | 6480464 | Estradiol results in increased expression of CCNB2 mRNA | CTD | PMID:15897899 PMID:16474171 | 17beta-estradiol | increases expression | EXP | | 6480464 | Estradiol results in increased expression of CCNB2 mRNA | CTD | PMID:20826375 | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | EXP | | 6480464 | Dihydrotestosterone results in increased expression of CCNB2 mRNA | CTD | PMID:17023530 | 2,2',4,4',5,5'-hexachlorobiphenyl | affects expression | EXP | | 6480464 | 2,4,5,2',4',5'-hexachlorobiphenyl affects the expression of CCNB2 mRNA | CTD | PMID:15201435 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | RGD:1317801 | 6480464 | Tetrachlorodibenzodioxin results in increased expression of CCNB2 mRNA | CTD | PMID:11007951 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:1317801 | 6480464 | Tetrachlorodibenzodioxin affects the expression of CCNB2 mRNA | CTD | PMID:22298810 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | EXP | | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCNB2 mRNA | CTD | PMID:17942748 | 2,3,7,8-tetrachlorodibenzodioxine | decreases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in decreased expression of CCNB2 mRNA | CTD | PMID:16611356 | 2,3-dimethoxynaphthalene-1,4-dione | increases expression | ISO | RGD:1317801 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of CCNB2 mRNA | CTD | PMID:19031421 PMID:17547211 | 2,3-dimethoxynaphthalene-1,4-dione | increases expression | ISO | RGD:1317801 | 6480464 | 2,3-dimethoxy-1,4-naphthoquinone results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 PMID:19031421 | 2-acetamidofluorene | increases expression | ISO | RGD:1308176 | 6480464 | 2-Acetylaminofluorene results in increased expression of CCNB2 mRNA | CTD | PMID:19167416 | 2-acetamidofluorene | increases expression | ISO | RGD:1308176 | 6480464 | 2-Acetylaminofluorene results in increased expression of CCNB2 mRNA | CTD | PMID:19167416 PMID:22584684 | 2-acetamidofluorene | multiple interactions | EXP | | 6480464 | TRP53 protein modified form affects the reaction [2-Acetylaminofluorene affects the expression of CCNB2 mRNA] | CTD | PMID:17317680 | 2-acetamidofluorene | increases expression | EXP | | 6480464 | 2-Acetylaminofluorene results in increased expression of CCNB2 mRNA | CTD | PMID:17317680 | 3,3',4,4'-tetrachlorobiphenyl | affects expression | ISO | RGD:1317801 | 6480464 | 3,4,3',4'-tetrachlorobiphenyl affects the expression of CCNB2 mRNA | CTD | PMID:20638727 | 3-methylcholanthrene | increases expression | EXP | | 6480464 | Methylcholanthrene results in increased expression of CCNB2 mRNA | CTD | PMID:20713471 | 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of CCNB2 mRNA | CTD | PMID:18648102 | 5-fluorouracil | decreases expression | ISO | RGD:1317801 | 6480464 | Fluorouracil results in decreased expression of CCNB2 mRNA | CTD | PMID:16709241 PMID:16557594 | 5-fluorouracil | decreases expression | EXP | | 6480464 | Fluorouracil results in decreased expression of CCNB2 mRNA | CTD | PMID:19272435 | 5-fluorouracil | decreases expression | ISO | RGD:1317801 | 6480464 | Fluorouracil results in decreased expression of CCNB2 mRNA | CTD | PMID:16557594 PMID:16709241 | 5-fluorouracil | decreases expression | ISO | RGD:1317801 | 6480464 | Fluorouracil results in decreased expression of CCNB2 protein | CTD | PMID:17982488 | 5-fluorouracil | multiple interactions | ISO | RGD:1317801 | 6480464 | TP53 protein affects the reaction [Fluorouracil results in decreased expression of CCNB2 mRNA] | CTD | PMID:15016801 | all-trans-retinoic acid | decreases expression | ISO | RGD:1317801 | 6480464 | Tretinoin results in decreased expression of CCNB2 mRNA | CTD | PMID:16574167 | all-trans-retinoic acid | increases expression | EXP | | 6480464 | Tretinoin results in increased expression of CCNB2 mRNA | CTD | PMID:17198874 | antimony(0) | increases expression | ISO | RGD:1317801 | 6480464 | Antimony results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | arsenite(3-) | decreases expression | EXP | | 6480464 | arsenite results in decreased expression of CCNB2 mRNA | CTD | PMID:18929588 | benomyl | increases response to substance | ISO | RGD:1317801 | 6480464 | CCNB2 protein results in increased susceptibility to Benomyl | CTD | PMID:11960377 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:17942131 more ... | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of CCNB2 mRNA | CTD | PMID:21964900 PMID:22610609 | benzo[a]pyrene | decreases expression | ISO | RGD:1317801 | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:20064835 more ... | benzo[a]pyrene | decreases expression | ISO | RGD:1317801 | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:20064835 PMID:22316170 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:19770486 more ... | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:20504355 more ... | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:20504355 PMID:17942131 | benzo[a]pyrene | decreases expression | ISO | RGD:1317801 | 6480464 | Benzo(a)pyrene results in decreased expression of CCNB2 mRNA | CTD | PMID:20064835 | bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of CCNB2 mRNA | CTD | PMID:15674843 | bisphenol A | affects expression | ISO | RGD:1317801 | 6480464 | bisphenol A affects the expression of CCNB2 mRNA | CTD | PMID:19490990 | bisphenol A | increases expression | ISO | RGD:1317801 | 6480464 | bisphenol A results in increased expression of CCNB2 mRNA | CTD | PMID:16474171 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of CCNB2 mRNA | CTD | PMID:20826375 | budesonide | decreases expression | EXP | | 6480464 | Budesonide results in decreased expression of CCNB2 mRNA | CTD | PMID:17163412 | cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:20061341 | calcitriol | affects expression | ISO | RGD:1317801 | 6480464 | Calcitriol affects the expression of CCNB2 mRNA | CTD | PMID:21592394 | calcitriol | multiple interactions | ISO | RGD:1317801 | 6480464 | Calcitriol promotes the reaction [Testosterone results in decreased expression of CCNB2 mRNA] | CTD | PMID:21592394 | cefaloridine | decreases expression | ISO | RGD:1308176 | 6480464 | Cephaloridine results in decreased expression of CCNB2 mRNA | CTD | PMID:18500788 | chlorpromazine | decreases expression | ISO | RGD:1317801 | 6480464 | Chlorpromazine analog results in decreased expression of CCNB2 mRNA; more ... | CTD | PMID:15924885 | chlorpyrifos | decreases expression | EXP | | 6480464 | Chlorpyrifos results in decreased expression of CCNB2 mRNA | CTD | PMID:20350560 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCNB2 gene | CTD | PMID:20938992 | chromium atom | increases expression | ISO | RGD:1317801 | 6480464 | Chromium results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | cisplatin | multiple interactions | ISO | RGD:1317801 | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of CCNB2 mRNA] | CTD | PMID:21858171 | cobalt dichloride | decreases expression | ISO | RGD:1317801 | 6480464 | cobaltous chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:19320972 PMID:19376846 | copper atom | multiple interactions | ISO | RGD:1317801 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCNB2 mRNA | CTD | PMID:20971185 | copper atom | increases expression | ISO | RGD:1308176 | 6480464 | Copper results in increased expression of CCNB2 mRNA | CTD | PMID:22465980 | copper(0) | multiple interactions | ISO | RGD:1317801 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of CCNB2 mRNA | CTD | PMID:20971185 | copper(0) | increases expression | ISO | RGD:1308176 | 6480464 | Copper results in increased expression of CCNB2 mRNA | CTD | PMID:22465980 | copper(2+) sulfate | decreases expression | ISO | RGD:1317801 | 6480464 | Copper Sulfate results in decreased expression of CCNB2 mRNA | CTD | PMID:19549813 | coumarin | decreases expression | ISO | RGD:1308176 | 6480464 | coumarin results in decreased expression of CCNB2 mRNA | CTD | PMID:18480146 | coumestrol | multiple interactions | ISO | RGD:1317801 | 6480464 | [Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CCNB2 mRNA; more ... | CTD | PMID:19167446 | coumestrol | increases expression | ISO | RGD:1317801 | 6480464 | Coumestrol results in increased expression of CCNB2 mRNA | CTD | PMID:19167446 | cyclosporin A | decreases expression | ISO | RGD:1317801 | 6480464 | Cyclosporine results in decreased expression of CCNB2 mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | RGD:1317801 | 6480464 | Cyclosporine results in decreased expression of CCNB2 mRNA | CTD | PMID:20106945 PMID:21632981 | cyclosporin A | decreases expression | EXP | | 6480464 | Cyclosporine results in decreased expression of CCNB2 mRNA | CTD | PMID:17942131 | diarsenic trioxide | increases expression | ISO | RGD:1317801 | 6480464 | arsenic trioxide results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CCNB2 mRNA | CTD | PMID:21266533 | dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of CCNB2 mRNA | CTD | PMID:17361019 PMID:21266533 | dipotassium bis[mu-tartrato(4-)]diantimonate(2-) trihydrate | increases expression | ISO | RGD:1317801 | 6480464 | Antimony Potassium Tartrate results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | doxorubicin | affects response to substance | ISO | RGD:1317801 | 6480464 | CCNB2 protein affects the susceptibility to Doxorubicin | CTD | PMID:16217747 | emodin | decreases expression | ISO | RGD:1317801 | 6480464 | Emodin results in decreased expression of CCNB2 mRNA | CTD | PMID:16045814 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCNB2 gene | CTD | PMID:20938992 | fulvestrant | multiple interactions | ISO | RGD:1317801 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of CCNB2 mRNA | CTD | PMID:19016759 | fulvestrant | decreases expression | ISO | RGD:1317801 | 6480464 | fulvestrant results in decreased expression of CCNB2 mRNA | CTD | PMID:19016759 | furan | increases expression | ISO | RGD:1308176 | 6480464 | furan results in increased expression of CCNB2 mRNA | CTD | PMID:22079235 | genistein | affects expression | ISO | RGD:1317801 | 6480464 | Genistein affects the expression of CCNB2 mRNA | CTD | PMID:18847459 | genistein | increases expression | ISO | RGD:1317801 | 6480464 | Genistein results in increased expression of CCNB2 mRNA | CTD | PMID:16474171 | genistein | decreases expression | ISO | RGD:1317801 | 6480464 | Genistein results in decreased expression of CCNB2 mRNA | CTD | PMID:16865672 | hydrogen peroxide | affects expression | ISO | RGD:1317801 | 6480464 | Hydrogen Peroxide affects the expression of CCNB2 mRNA | CTD | PMID:20044591 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of CCNB2 gene | CTD | PMID:20938992 | leptomycin B | decreases expression | ISO | RGD:1317801 | 6480464 | leptomycin B results in decreased expression of CCNB2 mRNA | CTD | PMID:20803015 | lidocaine | affects expression | EXP | | 6480464 | Lidocaine affects the expression of CCNB2 mRNA | CTD | PMID:18931217 | lithium atom | increases expression | ISO | RGD:1308176 | 6480464 | Lithium results in increased expression of CCNB2 mRNA | CTD | PMID:21711903 | lithium chloride | decreases expression | ISO | RGD:1317801 | 6480464 | Lithium Chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:15711924 PMID:17440966 | lithium chloride | decreases expression | ISO | RGD:1317801 | 6480464 | Lithium Chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:17440966 PMID:15711924 | lucanthone | decreases expression | ISO | RGD:1317801 | 6480464 | Lucanthone results in decreased expression of CCNB2 mRNA | CTD | PMID:21148553 | manganese atom | decreases expression | ISO | RGD:1317801 | 6480464 | Manganese results in decreased expression of CCNB2 mRNA | CTD | PMID:17175027 | manganese(0) | decreases expression | ISO | RGD:1317801 | 6480464 | Manganese results in decreased expression of CCNB2 mRNA | CTD | PMID:17175027 | manganese(II) chloride | decreases expression | ISO | RGD:1317801 | 6480464 | manganese chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:17175027 | menadione | affects expression | ISO | RGD:1317801 | 6480464 | Vitamin K 3 affects the expression of CCNB2 mRNA | CTD | PMID:20044591 | mercury atom | increases expression | ISO | RGD:1317801 | 6480464 | Mercury results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | mercury(0) | increases expression | ISO | RGD:1317801 | 6480464 | Mercury results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | methapyrilene | increases expression | ISO | RGD:1308176 | 6480464 | Methapyrilene results in increased expression of CCNB2 mRNA | CTD | PMID:22484513 | methapyrilene | increases expression | ISO | RGD:1308176 | 6480464 | Methapyrilene results in increased expression of CCNB2 mRNA | CTD | PMID:22484513 PMID:22584684 | methylmercury chloride | decreases expression | EXP | | 6480464 | methylmercuric chloride results in decreased expression of CCNB2 mRNA | CTD | PMID:20061341 | N-nitrosodiethylamine | increases expression | EXP | | 6480464 | Diethylnitrosamine results in increased expression of CCNB2 mRNA | CTD | PMID:17854601 | N-nitrosodiethylamine | multiple interactions | EXP | | 6480464 | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CCNB2 mRNA] | CTD | PMID:17854601 | naphthalene | increases expression | EXP | | 6480464 | naphthalene results in increased expression of CCNB2 mRNA | CTD | PMID:18978301 | nickel atom | increases expression | ISO | RGD:1317801 | 6480464 | Nickel results in increased expression of CCNB2 mRNA | CTD | PMID:19031421 | nickel dichloride | increases expression | ISO | RGD:1317801 | 6480464 | nickel chloride results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | ochratoxin A | increases expression | ISO | RGD:1308176 | 6480464 | ochratoxin A results in increased expression of CCNB2 mRNA | CTD | PMID:19717638 | ochratoxin A | increases expression | ISO | RGD:1308176 | 6480464 | ochratoxin A results in increased expression of CCNB2 mRNA | CTD | PMID:19237604 PMID:19717638 | ochratoxin A | increases expression | ISO | RGD:1308176 | 6480464 | ochratoxin A results in increased expression of CCNB2 mRNA | CTD | PMID:19717638 PMID:19237604 | okadaic acid | affects expression | ISO | RGD:1317801 | 6480464 | Okadaic Acid affects the expression of CCNB2 mRNA | CTD | PMID:21512803 | ozone | multiple interactions | EXP | | 6480464 | TTPA protein affects the reaction [Ozone results in increased expression of CCNB2 mRNA] | CTD | PMID:19555225 | paclitaxel | affects response to substance | ISO | RGD:1317801 | 6480464 | CCNB2 protein affects the susceptibility to Paclitaxel | CTD | PMID:16217747 | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of CCNB2 mRNA | CTD | PMID:17942131 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of CCNB2 mRNA | CTD | PMID:17562736 | phenobarbital | multiple interactions | EXP | | 6480464 | NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CCNB2 mRNA] | CTD | PMID:19482888 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CCNB2 mRNA | CTD | PMID:19482888 more ... | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CCNB2 mRNA | CTD | PMID:19482888 PMID:20403969 | phenobarbital | increases expression | EXP | | 6480464 | Phenobarbital results in increased expression of CCNB2 mRNA | CTD | PMID:20403969 PMID:19482888 | phorbol 13-acetate 12-myristate | increases expression | ISO | RGD:1317801 | 6480464 | Tetradecanoylphorbol Acetate results in increased expression of CCNB2 mRNA | CTD | PMID:19031421 | phorbol 13-acetate 12-myristate | multiple interactions | ISO | RGD:1317801 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCNB2 mRNA | CTD | PMID:16979875 | pirinixic acid | multiple interactions | EXP | | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CCNB2 mRNA | CTD | PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:1308176 | 6480464 | pirinixic acid results in increased expression of CCNB2 mRNA | CTD | PMID:22484513 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CCNB2 mRNA | CTD | PMID:17950772 PMID:18301758 | pirinixic acid | multiple interactions | EXP | | 6480464 | PPARA protein promotes the reaction [pirinixic acid results in increased expression of CCNB2 mRNA] | CTD | PMID:17950772 | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of CCNB2 mRNA | CTD | PMID:18301758 PMID:17950772 | piroxicam | multiple interactions | ISO | RGD:1317801 | 6480464 | Cisplatin affects the reaction [Piroxicam results in decreased expression of CCNB2 mRNA] | CTD | PMID:21858171 | piroxicam | decreases expression | ISO | RGD:1317801 | 6480464 | Piroxicam results in decreased expression of CCNB2 mRNA | CTD | PMID:21858171 | potassium dichromate | increases expression | ISO | RGD:1317801 | 6480464 | Potassium Dichromate results in increased expression of CCNB2 mRNA | CTD | PMID:17547211 | progesterone | increases expression | ISO | RGD:1317801 | 6480464 | Progesterone results in increased expression of CCNB2 mRNA | CTD | PMID:18070364 | propiconazole | increases expression | EXP | | 6480464 | propiconazole results in increased expression of CCNB2 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | RGD:1317801 | 6480464 | Quercetin results in decreased expression of CCNB2 mRNA | CTD | PMID:21632981 | resveratrol | decreases expression | ISO | RGD:1317801 | 6480464 | resveratrol results in decreased expression of CCNB2 mRNA | CTD | PMID:15767336 | resveratrol | multiple interactions | ISO | RGD:1317801 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA | CTD | PMID:19167446 | resveratrol | increases expression | ISO | RGD:1317801 | 6480464 | resveratrol results in increased expression of CCNB2 mRNA | CTD | PMID:19167446 | retinyl acetate | increases expression | EXP | | 6480464 | retinol acetate results in increased expression of CCNB2 mRNA | CTD | PMID:16772331 | sirolimus | multiple interactions | ISO | RGD:1317801 | 6480464 | [fulvestrant co-treated with Sirolimus] results in decreased expression of CCNB2 mRNA | CTD | PMID:19016759 | tacrolimus hydrate | decreases expression | ISO | RGD:1317801 | 6480464 | Tacrolimus results in decreased expression of CCNB2 mRNA | CTD | PMID:16574167 | tamoxifen | affects expression | EXP | | 6480464 | Tamoxifen affects the expression of CCNB2 mRNA | CTD | PMID:17555576 | tert-butyl hydroperoxide | increases expression | EXP | | 6480464 | tert-Butylhydroperoxide results in increased expression of CCNB2 mRNA | CTD | PMID:15003993 | testosterone | multiple interactions | ISO | RGD:1317801 | 6480464 | Calcitriol promotes the reaction [Testosterone results in decreased expression of CCNB2 mRNA] | CTD | PMID:21592394 | testosterone | decreases expression | ISO | RGD:1317801 | 6480464 | Testosterone results in decreased expression of CCNB2 mRNA | CTD | PMID:21592394 | tetrachloroethene | increases expression | ISO | RGD:1317801 | 6480464 | Tetrachloroethylene results in increased expression of CCNB2 mRNA | CTD | PMID:19031421 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of CCNB2 mRNA | CTD | PMID:17484886 | tetrachloromethane | multiple interactions | EXP | | 6480464 | PLG gene mutant form promotes the reaction [Carbon Tetrachloride results in increased expression of CCNB2 mRNA] | CTD | PMID:16006527 | thioacetamide | increases expression | ISO | RGD:1308176 | 6480464 | Thioacetamide results in increased expression of CCNB2 mRNA | CTD | PMID:22659510 | tocopherol | increases expression | EXP | | 6480464 | Tocopherols results in increased expression of CCNB2 mRNA | CTD | PMID:17056531 | topotecan | affects response to substance | ISO | RGD:1317801 | 6480464 | CCNB2 protein affects the susceptibility to Topotecan | CTD | PMID:16217747 | trans-resveratrol | decreases expression | ISO | RGD:1317801 | 6480464 | resveratrol results in decreased expression of CCNB2 mRNA | CTD | PMID:15767336 | trans-resveratrol | multiple interactions | ISO | RGD:1317801 | 6480464 | [Coumestrol co-treated with resveratrol] results in increased expression of CCNB2 mRNA | CTD | PMID:19167446 | trans-resveratrol | increases expression | ISO | RGD:1317801 | 6480464 | resveratrol results in increased expression of CCNB2 mRNA | CTD | PMID:19167446 | trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of CCNB2 mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | ISO | RGD:1317801 | 6480464 | troglitazone results in decreased expression of CCNB2 mRNA | CTD | PMID:19140230 | vincaleukoblastine | affects response to substance | ISO | RGD:1317801 | 6480464 | CCNB2 protein affects the susceptibility to Vinblastine | CTD | PMID:16217747 | vinyl carbamate | increases expression | EXP | | 6480464 | vinyl carbamate results in increased expression of CCNB2 mRNA | CTD | PMID:17163412 | zinc atom | multiple interactions | ISO | RGD:1317801 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCNB2 mRNA | CTD | PMID:16979875 | zinc atom | increases expression | ISO | RGD:1317801 | 6480464 | Zinc deficiency results in increased expression of CCNB2 mRNA | CTD | PMID:22171008 | zinc(0) | multiple interactions | ISO | RGD:1317801 | 6480464 | [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of CCNB2 mRNA | CTD | PMID:16979875 | zinc(0) | increases expression | ISO | RGD:1317801 | 6480464 | Zinc deficiency results in increased expression of CCNB2 mRNA | CTD | PMID:22171008 | |
Gene Ontology AnnotationsBiological Process











